Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Concerned medication change was early and possibly unnecessary. Should other tests have been done before the change?

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

Ask the Doctor Question:

I have SLL. I was switched from ibrutinib (had taken for almost 5 years) to Claquence (now taken 1-1/2 weeks) with only a few changed blood markers:

  • WBC went from 11.2 to 20.8
  • Absolute Lymphocytes from 6.83 to 14.4
  • Platelets from 200 to 159
  • Absolute Eosinophols from 0.3 to .42
  • LDH from 210 to 239
  • No other marked changes

None of these seem high enough to me to change my medication. No other testing was done. My two favorite doctors (ARNP’s) are gone – one for other opportunities, one for maternity leave. I see a new ARNP on Monday. I’m an information person and advocate for myself as I believe it is necessary. I’m concerned this medication change was early and possibly unnecessary. Should other tests have been done before the change?

Answer: We are with you in that we are not sure why the medication change occurred, except for that acalabrutinib tends to have less side effects than ibrutinib.